Collecting blood samples during IV busulfan treatment
This study looks at how to collect and handle blood samples from people receiving IV busulfan, a chemotherapy medicine. It may help improve the process of monitoring treatment by ensuring samples are collected correctly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a child or adult, and you are receiving treatment (male or female).
- You are currently getting busulfan through a vein (IV), not as pills.
- Your busulfan is being used for a blood-related condition (cancer or a non-cancer blood disease) that needs treatment.
- You (or your legal guardian if you’re under 18) can understand the study and sign consent forms before any study steps.
- If you’re under 18, you must be able to give assent, and your parent/guardian must sign consent.
- You must be willing and able to follow the study rules and provide required written consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to calculate the dose of the chemotherapy drug busulfan based on a child's body surface area, before a bone marrow transplant. The goal is to make dosing more accurate and possibly improve safety and effectiveness.
This trial tests a way to personalize the dose of a chemotherapy drug (busulfan) given before a stem cell transplant, based on how your body processes it. This could make the transplant safer and more effective for people who cannot tolerate the standard high-dose conditioning.
This study collects blood and bone marrow samples from patients with blood cancers to understand why treatments stop working. It aims to improve future treatments.
This study collects and stores tumor and blood samples from children and young adults with cancer, blood disorders, or immune conditions. The samples are used to better understand these diseases and could help future treatments.
This study looks at blood samples from people with blood cancers to find markers that might predict how well immunotherapy will work. The goal is to help doctors choose the right treatment for each person.
This study collects and stores blood/tissue samples (called biospecimens) to support immunotherapy research at the cancer center. If you may qualify, your samples help researchers test new immune-based cancer treatments.
Hear when a new Subjects Treated With Busulfan trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.